Angiogenesis and bladder cancer: Trendy prognostic factor or new therapeutic target?;Angiogenèse et cancer de vessie: Marqueur tumoral à la mode ou nouvelle cible thérapeutique?

Annales d'Urologie

Volumn 36, Issue 4, 2002, Pages 258-263

  Jayet, C ^a   Deperthes, D ^a   Leisinger, H J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Angiogenesis; Angiostatin; Bladder cancer; Endostatin

Indexed keywords

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CANCER THERAPY; ENDOTHELIUM CELL; PHENOTYPE; PROGNOSIS;

EID: 0036068162     PISSN: 00034401     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4401(02)00105-5     Document Type: Article

References (54)

1. The role of angiogenesis in tumor growth
2. Tumor dormancy in vivo by prevention of neovascularization
3. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
4. Relation of neovascularisation to metastasis in non-small-cell lung cancer
5. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma
6. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
7. Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor
8. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
9. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis
10. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
11. Macrophage-derived angiogenesis factors
12. Angiogenesis in bladder cancer
13. How tumors become angiogenic
14. Angiogenic activity as a marker of neoplastic and preneoplastic lesions of the human bladder
15. Detection of angiogenesis activity in malignant bladder tissue and cells
16. Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer
17. Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells
18. Fluorescein angiography of the bladder: Technique and relevance to bladder cancer and interstitial cystitis patients
19. Anti-tumor effect of angiogenesis inhibitor AGM 1470 on rat urinary bladder carcinoma induced by BBN
20. Angiogenesis inhibitor TNP-470 suppresses tumorigenesis in rat urinary bladder
21. Antitumour effects of the angiogenesis inhibitor AGM-1470 on rat urinary bladder tumours induced by N-Butyl-N-(4-hydroxybutyl) nitrosamine
22. Inhibition of basic fibroblast growth factor expression, angiogenesis, and growth of human bladder carcinoma in mice by systemic interferon-alpha administration
23. Basic fibroblast growth factor (bFGF) is a mediator of the tumorigenic phenotype in human transitional cell carcinoma of the bladder
24. Local overexpression of antiangiogenic factors decreases subcutaneous NBT-II bladder tumour growth in the nude mouse
25. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas
26. Angiogenesis in bladder cancer: Relationship between microvessel density and tumor prognosis
27. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer
28. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder
29. Prognostic significance of angiogenesis and immunoreactivity of cathepsin D and type IV collagen in high-grade stage T1 primary bladder cancer
30. Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients
31. Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine
32. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder
33. Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer
34. Different angiogenic pathways characterize superficial and invasive bladder cancer
35. Inhibition of angiogenesis by thrombospondin-2
36. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
37. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression
38. Overexpression of thrombospondin-1 inhibits bladder tumor growth: A novel therapy for invasive bladder cancer
39. Intravesical bacillus Calmette-Guerin (BCG) induces the anti-angiogenic chemokine IP-10: A proposed novel mechanism for BCG's anti-tumor activity
40. Intravesical bacille Calmette-Guerin induces the antiangiogenic chemokine interferon-inducible protein 10
41. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
42. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
43. Angiostatin induces and sustains dormancy of human primary tumors in mice
44. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
45. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
46. Angiostatin gene transfer: Inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest
47. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases
48. Adeno-associated virus-mediated delivery of antiangiogenic factors as an antitumor strategy
49. Combined effects of angiostatin and ionizing radiation in antitumour therapy
50. Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin
51. Are angiostatin and endostatin cures for cancer?
52. Angiogenesis antagonists: Current clinical trials
53. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
54. Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents